517 related articles for article (PubMed ID: 19236603)
1. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
2. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS).
Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J
Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
4. Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy.
Miyahara H; Okazaki N; Nagakura T; Korematsu S; Izumi T
Clin Exp Allergy; 2011 Feb; 41(2):186-91. PubMed ID: 21054588
[TBL] [Abstract][Full Text] [Related]
5. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
[TBL] [Abstract][Full Text] [Related]
7. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
Shimada Y; Takehara K; Sato S
J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
[TBL] [Abstract][Full Text] [Related]
8. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
[TBL] [Abstract][Full Text] [Related]
9. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
10. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
11. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Fok TF
Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.
Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H
J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
15. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
16. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
17. Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria.
Machura E; Rusek-Zychma M; Jachimowicz M; Wrzask M; Mazur B; Kasperska-Zajac A
Pediatr Allergy Immunol; 2012 May; 23(3):278-84. PubMed ID: 22017510
[TBL] [Abstract][Full Text] [Related]
18. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type.
Kabashima-Kubo R; Nakamura M; Sakabe J; Sugita K; Hino R; Mori T; Kobayashi M; Bito T; Kabashima K; Ogasawara K; Nomura Y; Nomura T; Akiyama M; Shimizu H; Tokura Y
J Dermatol Sci; 2012 Jul; 67(1):37-43. PubMed ID: 22591815
[TBL] [Abstract][Full Text] [Related]
19. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis.
Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z
Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
Gu CY; Gu L; Dou X
Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]